{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T11:24:35Z","timestamp":1743161075339},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,17]]},"DOI":"10.7759\/cureus.19655","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T11:02:42Z","timestamp":1637146962000},"source":"Crossref","is-referenced-by-count":3,"title":["Occurrence of Guillain-Barre Syndrome During the Initial Symptomatic Phase of COVID-19 Disease: Coincidence or Consequence?"],"prefix":"10.7759","author":[{"given":"Rui","family":"Seixas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Campoamor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hip\u00f3lito","family":"Nzwalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulce","family":"Pascoalinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14218\/ERHM.2017.00035","article-title":"Guillain-Barre syndrome following viral infections: considerations for future treatment and research","volume":"3","author":"Wang L","year":"2018","unstructured":"Wang L. Guillain-Barre syndrome following viral infections: considerations for future treatment and research. Explor Res Hypothesis Med. 2018, 3:4-5. 10.14218\/ERHM.2017.00035","journal-title":"Explor Res Hypothesis Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano G","year":"2020","unstructured":"Toscano G, Palmerini F, Ravaglia S, et al.. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2. N Engl J Med. 2020, 382:2574-6. 10.1056\/NEJMc2009191","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.2065","article-title":"Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review","volume":"77","author":"Zubair AS","year":"2020","unstructured":"Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020, 77:1018-27. 10.1001\/jamaneurol.2020.2065","journal-title":"JAMA Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577658","article-title":"Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms","volume":"358","author":"Johansson A","year":"2021","unstructured":"Johansson A, Mohamed MS, Moulin TC, Schi\u00f6th HB. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms. J Neuroimmunol. 2021, 358:577658. 10.1016\/j.jneuroim.2021.577658","journal-title":"J Neuroimmunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-021-00138-9","article-title":"Neurological manifestations of COVID-19 - an approach to categories of pathology","volume":"3","author":"Leven Y","year":"2021","unstructured":"Leven Y, B\u00f6sel J. Neurological manifestations of COVID-19 - an approach to categories of pathology. Neurol Res Pract. 2021, 3:39. 10.1186\/s42466-021-00138-9","journal-title":"Neurol Res Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu B","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021, 19:141-54. 10.1038\/s41579-020-00459-7","journal-title":"Nat Rev Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577590","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: a case report with long term follow up","volume":"356","author":"Papri N","year":"2021","unstructured":"Papri N, Hayat S, Mohammed A, et al.. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: a case report with long term follow up. J Neuroimmunol. 2021, 356:577590. 10.1016\/j.jneuroim.2021.577590","journal-title":"J Neuroimmunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.105921","article-title":"Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review","volume":"194","author":"Montalvan V","year":"2020","unstructured":"Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg. 2020, 194:105921. 10.1016\/j.clineuro.2020.105921","journal-title":"Clin Neurol Neurosurg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09996-w","article-title":"First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease","volume":"267","author":"Domingues RB","year":"2020","unstructured":"Domingues RB, Mendes-Correa MC, de Moura Leite FB, et al.. First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease. J Neurol. 2020, 267:3154-6. 10.1007\/s00415-020-09996-w","journal-title":"J Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/77072-occurrence-of-guillain-barre-syndrome-during-the-initial-symptomatic-phase-of-covid-19-disease-coincidence-or-consequence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:49Z","timestamp":1707506989000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/77072-occurrence-of-guillain-barre-syndrome-during-the-initial-symptomatic-phase-of-covid-19-disease-coincidence-or-consequence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.19655","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,17]]}}}